Corvus Pharmaceuticals Inc (NASDAQ:CRVS)

2.05
Delayed Data
As of Apr 02
 -0.17 / -7.66%
Today’s Change
1.01
Today|||52-Week Range
8.10
-62.32%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
AssetsCash4.1M5.1M45.1M39.2M
 
 
 
 
 
Short Term Investment Cash-8.4M945.0K40.1M-5.9M
 
 
 
 
 
Cash & Short Term Investments94.4M134.9M90.1M114.6M
 
 
 
 
 
 
ReceivablesReceivables0.00365.0K132.0K337.0K
 
 
 
 
 
InventoriesInventories0.000.000.000.00--
 
Current AssetsPrepaid Expenses--0.00327.0K390.0K
 
 
 
Other Current Assets1.3M772.0K720.0K265.0K
 
 
 
 
 
Current Assets95.7M136.0M91.2M115.6M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross2.0M4.0M4.2M4.6M
 
 
 
 
 
Depreciation-135.0K-729.0K-1.6M-2.4M
 
 
 
 
 
Other Assets951.0K869.0K869.0K463.0K
 
 
 
 
 
Total Assets98.5M140.2M94.8M118.2M
 
 
 
 
 
 
LiabilitiesAccounts Payable0.000.003.5M2.0M
 
 
 
Accrued Expenses967.0K3.5M4.9M4.4M
 
 
 
 
 
Other Current Liabilities2.8M5.4M4.9M4.4M
 
 
 
 
 
Other Liabilities3.1M5.9M9.0M7.0M
 
 
 
 
 
 
Total LiabilitiesOther Liabilities710.0K1.4M971.0K869.0K
 
 
 
 
 
Total Liabilities3.8M7.3M9.9M7.9M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock125.8M0.000.000.00
 
 
Common Equity-31.1M132.8M84.8M110.3M
 
 
 
 
 
Total Shareholder Equity94.7M132.8M84.8M110.3M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding21.1M20.9M21.0M29.3M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.